These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 21435278)

  • 21. Muscle aches and pains from statin use. Discomfort usually resolves with a lower dose or a different statin.
    Harv Heart Lett; 2012 Oct; 23(2):5. PubMed ID: 23437465
    [No Abstract]   [Full Text] [Related]  

  • 22. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
    Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
    Nishimoto T; Ishikawa E; Anayama H; Hamajyo H; Nagai H; Hirakata M; Tozawa R
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):39-45. PubMed ID: 17599378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase].
    Fuentes I; Aguilera C
    Med Clin (Barc); 1998 Nov; 111(18):700. PubMed ID: 9887435
    [No Abstract]   [Full Text] [Related]  

  • 26. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC; Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current overview of statin-induced myopathy.
    Rosenson RS
    Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation?
    Koumis T; Nathan JP; Rosenberg JM; Cicero LA
    Am J Health Syst Pharm; 2004 Mar; 61(5):515-9. PubMed ID: 15018231
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin myopathy.
    Radcliffe KA; Campbell WW
    Curr Neurol Neurosci Rep; 2008 Jan; 8(1):66-72. PubMed ID: 18367041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin-induced myopathy: the two faces of Janus.
    Arora R; Liebo M; Maldonado F
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presymptomatic neuromuscular disorders disclosed following statin treatment.
    Tsivgoulis G; Spengos K; Karandreas N; Panas M; Kladi A; Manta P
    Arch Intern Med; 2006 Jul; 166(14):1519-24. PubMed ID: 16864763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosuvastatin: characterization of induced myopathy in the rat.
    Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
    Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.
    Evangelista T; Ferro J; Pereira P; de Carvalho M
    Neuromuscul Disord; 2009 Jan; 19(1):66-8. PubMed ID: 19084404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA
    Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin-associated myopathy.
    Hamilton-Craig I
    Med J Aust; 2001 Nov; 175(9):486-9. PubMed ID: 11758079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.